Neuropsychiatric Symptoms of Epilepsy

14 Dementia
249
72. Golarai G, Greenwood AC, Feeney DM, Connor JA. Physiological and structural evidence
for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury.
J Neurosci. 2001;21:8523–37.
73. Pauli E, Hildebrandt M, Romstöck J, Stefan H, Blümcke I. Deficient memory acquisition in
temporal lobe epilepsy is predicted by hippocampal granule cell loss. Neurology.
2006;67:1383–9. doi: 10.1212/01.wnl.0000239828.36651.73 .
74. Ng SK, Hauser WA, Brust J, Susser M. Hypertension and the risk of new-onset unprovoked
seizures. Neurology. 1993;43:425–8. doi: 10.1212/wnl.43.2.425 .
75. Conrad J, Pawlowski M, Dogan MJ, Kovac S, Ritter MA, Evers S. Seizures after cerebrovascular
events: risk factors and clinical features. Seizure. 2013;22:275–82. doi: 10.1016/j.
seizure.2013.01.014 .
76. Noebels J. A perfect storm: converging paths of epilepsy and Alzheimer’s dementia intersect
in the hippocampal formation. Epilepsia. 2011;52 Suppl 1:39–46.
doi: 10.1111/j.1528-1167.2010.02909.x .
77. Prevett M, Enevoldson TP, Duncan JS. Adult onset acid maltase deficiency associated with
epilepsy and dementia: a case report. J Neurol Neurosurg Psychiatry. 1992;55:509.
doi: 10.1136/jnnp.55.6.509 .
78. Larner AJ. Presenilin-1 mutation Alzheimer’s disease: a genetic epilepsy syndrome? Epilepsy
Behav. 2011;21:20–2. doi: 10.1016/j.yebeh.2011.03.022 .
79. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer’s
disease and vascular dementia in developing countries: prevalence, management, and risk
factors. Lancet Neurol. 2008;7:812–26. doi: 10.1016/S1474-4422(08)70169-8 .
80. Korczyn AD. Mixed dementia--the most common cause of dementia. Ann N Y Acad Sci.
2002;977:129–34. doi: 10.1111/j.1749-6632.2002.tb04807.x .
81. Zekry D, Duyckaerts C, Hauw JJ. Mixed dementia: a neuropathologic point od view. Psychol
Neuropsychiatr Vieil. 2005;3:251–9.
82. Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform
activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70:1158–66.
doi: 10.1001/jamaneurol.2013.136 .
83. Rabinowicz AL, Starkstein SE, Leiguarda RC, Coleman AE. Transient epileptic amnesia in
dementia: a treatable unrecognized cause of episodic amnestic wandering. Alzheimer Dis
Assoc Disord. 2000;14:231–3. doi: 10.1097/00002093-200010000-00008 .
84. Sinforiani E, Manni R, Bernasconi L, Banchieri LM, Zucchella C. Memory disturbances and
temporal lobe epilepsy simulating Alzheimer’s disease: a case report. Funct Neurol.
2003;8:39–41.
85. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory
neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse
models of Alzheimer’s disease. Neuron. 2007;55:697–711. doi: 10.1016/j.
neuron.2007.07.025 .
86. Velez-Pardo C, Arellano JI, Cardona-Gomez P, Jimenez Del Rio M, Lopera F, De Felipe
J. CA1 hippocampal neuronal loss in familial Alzheimer’s disease presenilin-1 E280
Amutation is related to epilepsy. Epilepsia. 2004;45:751–6.
doi: 10.1111/j.0013-9580.2004.55403.x .
87. Hatanpaa KJ, Raisanen JM, Herndon E, Burns DK, Foong C, Habib AA, et al. Hippocampal
sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal
subfields. J Neuropathol Exp Neurol. 2014;73:136–42. doi: 10.1097/OPX.0000000000000170 .
88. Timsit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, Khrestchatisky
M. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy:
a modulator of in vivo programmed cell death? Eur J Neurosci. 1999;11:263–78.
doi: 10.1046/j.1460-9568.1999.00434.x .
89. Szabo K, Förster A, Gass A. Conventional and diffusion-weighted MRI of the hippocampus.
Front Neurol Neurosci. 2014;34:71–84. doi: 10.1159/000357925 .